ODC faces renewed calls to monitor imports amid stockpiling concerns by Steve Jones August 15, 2024August 15, 2024 The Office of Drug Control (ODC) is facing renewed calls to ease the regulatory burden on […]
Full year revenue jumps 29% but ‘price pressure’ dents fourth quarter for ECS Botanics by Steve Jones July 29, 2024July 29, 2024
Indoor, glasshouse or outdoor growing? There’s room for all as industry aims to compete with the best by Steve Jones July 18, 2024July 18, 2024
Company news: ECS Botanics; Althea; InhaleRx; Neurotech International by Martin Lane and Steve Jones July 10, 2024July 11, 2024
ECS Botanics prepares for ‘massive shift’ towards retail strategy by Steve Jones May 29, 2024May 30, 2024
ECS strikes A$380k deal as firm launches direct-to-consumer sales by Steve Jones May 20, 2024May 23, 2024
ECS Botanics founder Alex Keach sells 50m shares and steps down from the board by Steve Jones May 6, 2024May 7, 2024
Record harvest and softer revenue hit ECS Botanics’ Q3 cash flow by Steve Jones April 29, 2024April 29, 2024
Local firms call for united voice to tackle import-export disparity as Australia is branded a cannabis ‘honeypot’ by Steve Jones March 27, 2024March 27, 2024
Launch of consumer strategy ‘not taken lightly’, as ECS Botanics looks to capitalise on ‘unique IP’ by Steve Jones March 11, 2024March 11, 2024
